Fermenta Biotech Limited (FERMENTA) — Announcement | 11 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Fermenta Biotech released Q1FY27 earnings presentation
🔄 What Changed
Human nutrition revenue up 24% QoQ; India revenue share rose to 47%; animal nutrition volumes down 52% QoQ
🔮 What's Next
FSSAI approval for VITADEE Green® on 6 July 2026; 7th place in Great Mid-size Workplaces 2026
💡 Investor Takeaway
Shareholders see near-term margin pressure but long-term growth in human nutrition and new product approvals.
⚠️ Risks
Animal nutrition segment under pressure with 52% QoQ volume decline and 40% lower realizations

Fermenta Biotech reported Q1FY27 revenue of INR 126.2 crore, down 13% YoY but flat QoQ, with human nutrition revenue rising 24% QoQ to INR 76.5 crore and India contributing 47% of consolidated revenue. EBITDA fell 39% YoY to INR 22.4 crore and profit after tax dropped 56% YoY to INR 9.5 crore, reflecting a strong prior-year base without exceptional items. The company highlighted growth in Vitamin D3 human nutrition, expanded API volumes, and new FSSAI approval for VITADEE Green®, while animal nutrition faced volume declines. Geographic diversification strengthened with India emerging as the largest revenue market.

📄 View Original Announcement (PDF)

About Fermenta Biotech Limited (FERMENTA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,471.99 Cr P/E: 24.3 ROE: 14.3% ROCE: 18.1% Div Yield: 0.75%

View full FERMENTA stock details →

📡 Get AI alerts when FERMENTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FERMENTA — Free

📊 More FERMENTA filings

See all FERMENTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FERMENTA files new disclosures

Track FERMENTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FERMENTA — Free

Free account · 2 AI queries/day